Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Natural History of Histologically-proven Alcohol Related Liver Disease: A systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Clinical translatability of a diet-induced obese mouse model of non-alcoholic steatohepatitis

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  3. HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Incidence of Hepatocellular Carcinoma in HIV/HBV-coinfected Patients on Tenofovir therapy: Relevance for Screening Strategies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Cirrhotic cardiomyopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • G Fattovich
  • G Giustina
  • F Degos
  • G Diodati
  • F Tremolada
  • F Nevens
  • P Almasio
  • A Solinas
  • J T Brouwer
  • H Thomas
  • G Realdi
  • R Corrocher
  • S W Schalm
Vis graf over relationer
The role of interferon alfa treatment in improving morbidity endpoints in patients with chronic hepatitis C infection is currently under debate. The aim of this study was to evaluate the effectiveness of interferon in preventing hepatocellular carcinoma and decompensation in cirrhosis type C.
OriginalsprogEngelsk
TidsskriftJournal of Hepatology
Vol/bind27
Udgave nummer1
Sider (fra-til)201-5
Antal sider5
ISSN0168-8278
DOI
StatusUdgivet - jul. 1997

ID: 38982469